Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018975
Filing Date
2016-05-10
Accepted
2016-05-10 16:38:17
Documents
44
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20160331.htm 10-Q 1377336
2 EX-10.1 xene-ex101_51.htm EX-10.1 24712
3 EX-31.1 xene-ex311_6.htm EX-31.1 17708
4 EX-31.2 xene-ex312_10.htm EX-31.2 18117
5 EX-32.1 xene-ex321_7.htm EX-32.1 8429
6 EX-32.2 xene-ex322_8.htm EX-32.2 8245
  Complete submission text file 0001564590-16-018975.txt   2883792

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT xene-20160331.xml EX-101.INS 331756
8 XBRL TAXONOMY EXTENSION SCHEMA xene-20160331.xsd EX-101.SCH 22343
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20160331_cal.xml EX-101.CAL 25239
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20160331_def.xml EX-101.DEF 30808
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20160331_lab.xml EX-101.LAB 154616
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20160331_pre.xml EX-101.PRE 110280
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 161636315
SIC: 2834 Pharmaceutical Preparations